Skip to main content

Aadi Bioscience Inc

For the period ended Sep 30, 2024. Filed Nov 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 6, 2024

WHWK$3.13+3.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Table of Contents

Page
PART I.FINANCIAL INFORMATION2
Item 1.Financial Statements2
Condensed Consolidated Balance Sheets – September 30, 2024 and December 31, 2023 (Unaudited)2
Condensed Consolidated Statements of Operations and Comprehensive Loss – Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited)3
Condensed Consolidated Statements of Stockholders’ Equity – Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited)4
Condensed Consolidated Statements of Cash Flows – Nine Months Ended September 30, 2024 and 2023 (Unaudited)6
Notes to Condensed Consolidated Financial Statements (Unaudited)7
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations26
Item 3.Quantitative and Qualitative Disclosures About Market Risk35
Item 4.Controls and Procedures35
PART II.OTHER INFORMATION36
Item 1.Legal Proceedings36
Item 1A.Risk Factors36
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds100
Item 3.Defaults Upon Senior Securities100
Item 4.Mine Safety Disclosures101
Item 5.Other Information101
Item 6.Exhibits102
Signatures103
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.